SCHEMBL7704890

SCHEMBL7704890

CCC1=C(N)Nc2cc(C(C)(NC(=O)OC(C)(C)C)c3cccs3)ccc2O1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.32
CTSS P25774 2/20 0.32
CTSL P07711 1/20 0.32
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7710991 0.93 CTSK (0.32) CTSKCTSSCTSL
SCHEMBL7708334 0.89 ALDH1A1 (0.32) CTSKCTSS
Hydrochloric Acid SCHEMBL6992620 0.79 ACE2 (0.32)
SCHEMBL7713259 0.79 USP2 (0.39)
SCHEMBL7708245 0.78 SMN1; SMN2 (0.31) CTSKCTSS
SCHEMBL7711367 0.78 USP2 (0.38)
SCHEMBL7711428 0.78 PARP1 (0.39)
SCHEMBL7089637 0.77 ALDH1A1 (0.32)
Hydrochloric Acid SCHEMBL8118427 0.75 ESR1 (0.31)
SCHEMBL7704894 0.75 CTSK (0.31) CTSKCTSSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed